title: Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.
authors.affiliation: Servicio de Dermatología, Hospital Universitario Cruces, Barakaldo, Vizcaya, España. Electronic address: adriandeq@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: de Quintana-Sancho
authors.affiliation: Servicio de Dermatología, Hospital Universitario Cruces, Barakaldo, Vizcaya, España.
authors.forename: E
authors.initials: E
authors.lastname: Acebo-Mariñas
authors.affiliation: Servicio de Dermatología, Hospital Universitario Cruces, Barakaldo, Vizcaya, España.
authors.forename: J
authors.initials: J
authors.lastname: Gardeazabal-García
authors.affiliation: Servicio de Anatomía Patológica, Hospital Universitario Cruces, Barakaldo, Vizcaya, España.
authors.forename: A
authors.initials: A
authors.lastname: Aperribay-Esparza
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000077610:Bexarotene; D001921:Brain / Q000473:pathology*; D002330:Carmustine / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000150:complications; D008569:Memory Disorders / Q000209:etiology*; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D009759:Nystagmus, Pathologic / Q000209:etiology*; D011701:PUVA Therapy; D012878:Skin Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D013764:Tetrahydronaphthalenes; D003561:Cytarabine; D000077610:Bexarotene; D002330:Carmustine; D008727:Methotrexate